Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background Population studies show that musculoskeletal conditions are a leading contributor to the total burden of healthy life lost, second only to cancer and with a similar burden to cardiovascular disease. Prioritizing the delivery of effective treatments is necessary, and with the ubiquity of consumer smart devices, the use of digital health interventions is increasing. Messaging is popular and easy to use and has been studied for a range of health-related uses, including health promotion, encouragement of behavior change, and monitoring of disease progression. It may have a useful role to play in the management and self-management of musculoskeletal conditions. Objective Previous reviews on the use of messaging for people with musculoskeletal conditions have focused on synthesizing evidence of effectiveness from randomized controlled trials. In this review, our objective was to map the musculoskeletal messaging literature more broadly to identify information that may inform the design of future messaging interventions and summarize the current evidence of efficacy, effectiveness, and economics. Methods Following a prepublished protocol developed using the Joanna Briggs Institute Manual for Evidence Synthesis, we conducted a comprehensive scoping review of the literature (2010-2022; sources: PubMed, CINAHL, Embase, and PsycINFO) related to SMS text messaging and app-based messaging for people with musculoskeletal conditions. We described our findings using tables, plots, and a narrative summary. Results We identified a total of 8328 papers for screening, of which 50 (0.6%) were included in this review (3/50, 6% previous reviews and 47/50, 94% papers describing 40 primary studies). Rheumatic diseases accounted for the largest proportion of the included primary studies (19/40, 48%), followed by studies on multiple musculoskeletal conditions or pain sites (10/40, 25%), back pain (9/40, 23%), neck pain (1/40, 3%), and “other” (1/40, 3%). Most studies (33/40, 83%) described interventions intended to promote positive behavior change, typically by encouraging increased physical activity and exercise. The studies evaluated a range of outcomes, including pain, function, quality of life, and medication adherence. Overall, the results either favored messaging interventions or had equivocal outcomes. While the theoretical underpinnings of the interventions were generally well described, only 4% (2/47) of the papers provided comprehensive descriptions of the messaging intervention design and development process. We found no relevant economic evaluations. Conclusions Messaging has been used for the care and self-management of a range of musculoskeletal conditions with generally favorable outcomes reported. However, with few exceptions, design considerations are poorly described in the literature. Further work is needed to understand and disseminate information about messaging content and message delivery characteristics, such as timing and frequency specifically for people with musculoskeletal conditions. Similarly, further work is needed to understand the economic effects of messaging and practical considerations related to implementation and sustainability. International Registered Report Identifier (IRRID) RR2-10.1136/bmjopen-2021-048964
Background Population studies show that musculoskeletal conditions are a leading contributor to the total burden of healthy life lost, second only to cancer and with a similar burden to cardiovascular disease. Prioritizing the delivery of effective treatments is necessary, and with the ubiquity of consumer smart devices, the use of digital health interventions is increasing. Messaging is popular and easy to use and has been studied for a range of health-related uses, including health promotion, encouragement of behavior change, and monitoring of disease progression. It may have a useful role to play in the management and self-management of musculoskeletal conditions. Objective Previous reviews on the use of messaging for people with musculoskeletal conditions have focused on synthesizing evidence of effectiveness from randomized controlled trials. In this review, our objective was to map the musculoskeletal messaging literature more broadly to identify information that may inform the design of future messaging interventions and summarize the current evidence of efficacy, effectiveness, and economics. Methods Following a prepublished protocol developed using the Joanna Briggs Institute Manual for Evidence Synthesis, we conducted a comprehensive scoping review of the literature (2010-2022; sources: PubMed, CINAHL, Embase, and PsycINFO) related to SMS text messaging and app-based messaging for people with musculoskeletal conditions. We described our findings using tables, plots, and a narrative summary. Results We identified a total of 8328 papers for screening, of which 50 (0.6%) were included in this review (3/50, 6% previous reviews and 47/50, 94% papers describing 40 primary studies). Rheumatic diseases accounted for the largest proportion of the included primary studies (19/40, 48%), followed by studies on multiple musculoskeletal conditions or pain sites (10/40, 25%), back pain (9/40, 23%), neck pain (1/40, 3%), and “other” (1/40, 3%). Most studies (33/40, 83%) described interventions intended to promote positive behavior change, typically by encouraging increased physical activity and exercise. The studies evaluated a range of outcomes, including pain, function, quality of life, and medication adherence. Overall, the results either favored messaging interventions or had equivocal outcomes. While the theoretical underpinnings of the interventions were generally well described, only 4% (2/47) of the papers provided comprehensive descriptions of the messaging intervention design and development process. We found no relevant economic evaluations. Conclusions Messaging has been used for the care and self-management of a range of musculoskeletal conditions with generally favorable outcomes reported. However, with few exceptions, design considerations are poorly described in the literature. Further work is needed to understand and disseminate information about messaging content and message delivery characteristics, such as timing and frequency specifically for people with musculoskeletal conditions. Similarly, further work is needed to understand the economic effects of messaging and practical considerations related to implementation and sustainability. International Registered Report Identifier (IRRID) RR2-10.1136/bmjopen-2021-048964
BACKGROUND Population studies show that musculoskeletal (MSK) conditions are a leading contributor to the total burden of healthy life lost, second only to cancer, and with a similar burden to cardiovascular disease; prioritising the delivery of effective treatments is needed and with the ubiquity of consumer smart devices, the use of digital health interventions is increasing. Text messaging is popular, easy to use, and has been studied for a range of health-related uses including health promotion, encouraging behaviour change, and monitoring disease progression; it may have a useful role to play in the management and self-management for people with MSK conditions. OBJECTIVE Previous reviews of the use of messaging for people with MSK conditions have focussed on synthesising evidence of effectiveness from RCTs. In this review, our objective was to map the MSK messaging literature more broadly, to identify information which may inform the design of future messaging interventions, and to summarise the current evidence of efficacy, effectiveness, and economics. METHODS Using a pre-published protocol developed using the Joanna Briggs Institute Manual for Evidence Synthesis, we conducted a comprehensive scoping review of the literature (2010-2022; sources PubMed, CINAHL, Embase, and PsycInfo) relating to SMS and app-based messaging for people with MSK conditions. We described our findings using tables, plots, and a narrative summary. RESULTS We identified a total of 8,328 papers for screening, of which 50 were included in this review (three previous reviews; 47 papers describing 40 primary studies). Rheumatic diseases accounted for the largest proportion of included primary studies 19/40 (47.5%), followed by studies of multiple MSK conditions or pain sites (10/40; 25%), back pain (9/40; 22.5%), neck pain (1/40; 2.5%), and ‘other’ (1/40; 2.5%). Most (33/40; 82.5%) studies described interventions intended to promote positive behaviour change, typically by encouraging increased physical activity and exercise. Studies evaluated a range of outcomes including pain, function, quality of life, and medication adherence. Overall, results either favoured messaging interventions or had equivocal outcomes. While the theoretical underpinnings of interventions were generally well described, only two papers provided comprehensive descriptions of messaging intervention design and development process. We found no economic evaluations of messaging interventions for people with MSK conditions. CONCLUSIONS Messaging has been used for the care and self-management of a range of MSK conditions with generally favourable outcomes reported. However, with few exceptions, design considerations are poorly described in the literature; further work is needed to understand and disseminate information about messaging content, and message delivery characteristics such as the timing and frequency specifically for people with MSK conditions. Similarly, further work is needed to understand the economic effects of messaging, and practical considerations relating to implementation and sustainability. CLINICALTRIAL N/A INTERNATIONAL REGISTERED REPORT RR2-https://doi.org/10.1136/bmjopen-2021-048964
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.